Telesis Bio, Inc.
Messenger RNA therapy for the treatment of Friedreich's ataxia
Last updated:
Abstract:
The present invention provides methods and compositions of treating Friedreich's ataxia (FRDA) based on administering an mRNA encoding a frataxin protein.
Status:
Grant
Type:
Utility
Filling date:
19 Jun 2018
Issue date:
22 Sep 2020